Catalent offers its partners end-to-end solutions, from early drug product development, formulation and drug delivery technologies, to manufacturing and clinical supply services.
Catalent offers its partners end-to-end solutions, from early drug product development, formulation, and drug delivery technologies, to manufacturing and clinical supply services. From its global network of facilities, Catalent supports the development and launch of over 100 new products annually.
Catalent has three early-phase drug development centers of excellence in Nottingham, UK, Somerset, New Jersey, and San Diego, California, that offer integrated analytical, pre-formulation, and formulation technologies, and give partners access to the most comprehensive bioavailability enhancing technology toolkit including lipid formulation, spray drying, and hot melt extrusion. It is with this depth of experience and expertise that each molecule’s unique characteristics and challenges can be overcome to create innovative, intelligent dose forms that benefit patients.
Catalent’s multi-award-winning OptiForm® Solution Suite platform is fast, flexible, and fact-based, combining the broadest selection of enabling technologies to ensure the right decisions are made at each stage of development to create oral dose forms that can improve a drug’s clinical efficacy and commercial success.
OptiForm Solution Suite includes a comprehensive range of candidate screening tools, ADME considerations, and in silico DMPK modelling, as well as additional bioavailability enhancing tools to provide materials for cGLP toxicological studies, and on to first-in-human studies.
For later-phase needs, Catalent can leverage its expertise in clinical and commercial supply with its network of manufacturing facilities that have been approved by 35 regulatory agencies to provide commercial and clinical manufacturing solutions.
Producing more than 70 billion doses annually, Catalent’s manufacturing sites offer flexible supply solutions and expertise in oral dose forms, as well as sterile, biologic and inhaled formulations. Catalent has proven expertise in technology transfers and product launches, custom suite models, and specialty handling (including highly potent/DEA-licenced compounds) to support a wide range of manufacturing requirements.